gene in clients relapsing following treatment Along with the BCL2 antagonist venetoclax. sixty six Resistance to these agents has long been connected to these mutations in close to 70% of circumstances, Even though they are often subclonal and their precise purpose causing resistance should be verified.??? "?????????????????????????????????????????